HLA-DR Expression on Monocyte Subsets in Critically Ill Children

Background: To longitudinally study blood monocyte subset distribution and human leukocyte antigen-DR (HLA-DR) expression on monocyte subsets in children with sepsis, post-surgery and trauma in relation to nosocomial infections and mortality. Methods: In 37 healthy children and 37 critically ill children (12 sepsis, 11 post-surgery, 10 trauma and 4 admitted for other reasons)—participating in a randomized controlled trial on early versus late initiation of parenteral nutrition—monocyte subset distribution and HLA-DR expression on monocyte subsets were measured by flow cytometry upon admission and on days 2, 3 and 4 of pediatric intensive care unit (PICU) stay. Results: Upon PICU admission, critically ill children had a higher proportion of classical monocytes (CD14++CD16−) than healthy children [PICU 95% (interquartile range [IQR] 88%–98%); controls, 87% (IQR 85%–90%), P < 0.001]. HLA-DR expression was significantly decreased within all monocyte subsets and at all time points, being most manifest on classical monocytes and in patients with sepsis. Percentage of HLA-DR expressing classical monocytes [upon PICU admission 67% (IQR 44%–88%); controls 95% (IQR 92%–98%), P < 0.001], as well as the HLA-DR mean fluorescence intensity [upon PICU admission 3219 (IQR 2650–4211); controls 6545 (IQR 5558–7647), P < 0.001], decreased during PICU stay. Patients who developed nosocomial infections (n = 13) or who died (n = 6) had lower HLA-DR expression on classical monocytes at day 2 (P = 0.002) and day 3 (P = 0.04), respectively. Conclusions: Monocytic HLA-DR expression decreased during PICU stay and was lower compared with controls on all examined time points, especially on classical monocytes and in children admitted for sepsis. Low HLA-DR expression on classical monocytes was associated with nosocomial infections and death.

[1]  R. Hotchkiss,et al.  Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study , 2016, Critical Care.

[2]  E. Troster,et al.  Prolonged suppression of monocytic human leukocyte antigen-DR expression correlates with mortality in pediatric septic patients in a pediatric tertiary Intensive Care Unit. , 2016, Journal of critical care.

[3]  G. Van den Berghe,et al.  Early versus Late Parenteral Nutrition in Critically Ill Children. , 2016, The New England journal of medicine.

[4]  M. Weigand,et al.  Sepsis-induced long-term immune paralysis – results of a descriptive, explorative study , 2016, Critical Care.

[5]  M. Netea,et al.  Interferon-gamma Immunotherapy in a Patient With Refractory Disseminated Candidiasis , 2015, The Pediatric infectious disease journal.

[6]  G. Van den Berghe,et al.  Impact of withholding early parenteral nutrition completing enteral nutrition in pediatric critically ill patients (PEPaNIC trial): study protocol for a randomized controlled trial , 2015, Trials.

[7]  M. Hofbeck,et al.  Patterns of monocyte subpopulations and their surface expression of HLA-DR during adverse events after hematopoietic stem cell transplantation , 2015, Annals of Hematology.

[8]  M. Hofbeck,et al.  Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation , 2015, Annals of Hematology.

[9]  R. Hotchkiss,et al.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy , 2013, Nature Reviews Immunology.

[10]  J. Talmadge,et al.  History of myeloid-derived suppressor cells , 2013, Nature Reviews Cancer.

[11]  R. Curi,et al.  Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: a randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer. , 2013, Clinical nutrition.

[12]  R. Hotchkiss,et al.  Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. , 2013, Current opinion in immunology.

[13]  M. Netea,et al.  Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? , 2013, American journal of respiratory and critical care medicine.

[14]  R. Hotchkiss,et al.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. , 2013, The Lancet. Infectious diseases.

[15]  J. Timsit,et al.  Inter‐laboratory assessment of flow cytometric monocyte HLA‐DR expression in clinical samples , 2013, Cytometry. Part B, Clinical cytometry.

[16]  D. Fliser,et al.  Monocyte heterogeneity in human cardiovascular disease. , 2012, Immunobiology.

[17]  T. Kalina,et al.  EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols , 2012, Leukemia.

[18]  L. Moldawer,et al.  Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care , 2012, The journal of trauma and acute care surgery.

[19]  M. Manz,et al.  Demand-adapted regulation of early hematopoiesis in infection and inflammation. , 2012, Blood.

[20]  S. Wong,et al.  The three human monocyte subsets: implications for health and disease , 2012, Immunologic Research.

[21]  F. Venet,et al.  Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions , 2011, Critical care.

[22]  Wing-Cheong Wong,et al.  Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. , 2011, Blood.

[23]  Y. Dou,et al.  Epigenetic regulation of immune cell functions during post-septic immunosuppression , 2011, Epigenetics.

[24]  Lyle L. Moldawer,et al.  A Paradoxical Role for Myeloid-Derived Suppressor Cells in Sepsis and Trauma , 2011, Molecular medicine.

[25]  Silvano Sozzani,et al.  Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.

[26]  N. Voirin,et al.  Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock , 2010, Intensive Care Medicine.

[27]  F. Tacke,et al.  Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults , 2010, BMC Immunology.

[28]  P. Pronovost,et al.  Long-term mortality and quality of life in sepsis: A systematic review* , 2010, Critical care medicine.

[29]  T. Baumann,et al.  Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. , 2009, American journal of respiratory and critical care medicine.

[30]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[31]  M. Zembala,et al.  Peripheral Blood CD14high CD16+ Monocytes are Main Producers of IL‐10 , 2008, Scandinavian journal of immunology.

[32]  D. Mosser,et al.  Monocyte subpopulations and their differentiation patterns during infection , 2007, Journal of leukocyte biology.

[33]  N. Voirin,et al.  Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock , 2006, Intensive Care Medicine.

[34]  G. Wanten An update on parenteral lipids and immune function: only smoke, or is there any fire? , 2006, Current opinion in clinical nutrition and metabolic care.

[35]  C. Meisel,et al.  Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. , 2005, Clinical chemistry.

[36]  I. Chaudry,et al.  Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches , 2005, Langenbeck's Archives of Surgery.

[37]  V. Rousson,et al.  Monocyte function-associated antigen expression during and after pediatric cardiac surgery. , 2005, The Journal of thoracic and cardiovascular surgery.

[38]  Alain Martinot,et al.  Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study , 2003, The Lancet.

[39]  C. Nebe,et al.  Age-related Low Expression of HLA-DR Molecules on Monocytes of Term and Preterm Newborns With and Without Signs of Infection , 2003, Journal of Perinatology.

[40]  I. Chaudry,et al.  The cellular basis of post-burn immunosuppression: macrophages and mediators. , 2002, International journal of molecular medicine.

[41]  J. Pryjma,et al.  CD14+CD16+ Monocytes in the Course of Sepsis in Neonates and Small Children: Monitoring and Functional Studies , 2002, Scandinavian journal of immunology.

[42]  R. Callard,et al.  Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care* , 2002, Critical care medicine.

[43]  K. Asadullah,et al.  Monocyte deactivation in septic patients: Restoration by IFN-γ treatment , 1997, Nature Medicine.

[44]  K. Asadullah,et al.  Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. , 1997, Archives of internal medicine.

[45]  C. Gogos,et al.  Total parenteral nutrition and immune system activity: a review. , 1995, Nutrition.